Glanz: Aging daily 1c935eb4987f40b494f80d5f78276ffc 95672e319d13

2026-10-08T07:30:03Z

Aging daily 1c935eb4987f40b494f80d5f78276ffc 95672e319d13

Neue Seite

__NOTOC__
<div class="aging-research-world aging-journal" lang="en">
<div class="aj-masthead"><div class="aj-brand"><span class="aj-monogram">[[Aging|a.]]</span><span>[[Aging|AGING]]<small>RESEARCH IN PROGRESS</small></span></div><div class="aging-languages" role="navigation" aria-label="Sprache / Language"><span class="aging-language" title="Deutsch">[[Altern/Forschungsberichte/2026-10-08|🇩🇪]]</span><span class="aging-language" title="English">[[Aging/Research reports/2026-10-08|🇬🇧]]</span></div></div>
<div class="aj-context"><strong>An evolving AI research project</strong>[[Aging/About the project|Background · goals · methods]]<span>Updated 8 Oct 2026</span></div>
<h1>What would a TIMP2 countercheck need to show?</h1>
<div class="aj-deck">Research report · 8 October 2026 · TIMP2 and informative counterchecks</div>
<div class="aj-article">

<div class="aj-kicker">Brain & proteins · A testable next step</div>
== A disappearing signal is not enough ==
'''Today's decision:''' A targeted score comparison excluding the APOE region remains unverified for AG-D06. We therefore specify in advance which result would strengthen or weaken an alternative explanation. This is '''our methodological reasoning, not a new study finding'''. AG-C03/AG-T01 remain '''🔵 Level 2, low confidence'''; the human observational study remains '''⚪ Level 1 with limited association evidence'''.

== What could be checked today ==
Anastasi et al., DOI '''10.1016/j.neurobiolaging.2025.10.003''': first online '''23 October 2025''', issue '''January 2026'''; today's access check '''8 October 2026'''. [https://pmc.ncbi.nlm.nih.gov/articles/PMC12646536/ Original study] · [https://pubmed.ncbi.nlm.nih.gov/41167043/ Publication record].

The main text read on 7 October documents single-variant tests and refers to supplementary tables. The supplement could not be verified today: the PMC request and observed supplement reference led to reCAPTCHA; the bounded search yielded no verified article-specific code link. Earlier blocked publisher/PDF requests were not repeated. '''Not read does not mean nonexistent.''' Today's report does not claim a new complete main-text review.

== Three questions, three different checks ==
Testing rs429358 alone asks about that variant's association. Stratifying by APOE carrier status examines subgroups. Only an actually recomputed score excluding a defined APOE region tests the remaining genetic score. These procedures cannot substitute for one another. Variant annotation or biological enrichment is not evidence of colocalisation either.

'''Our proposed countercheck:''' Compare the original score and the APOE-excluded score in the same people, using the same PACC outcome and covariates. The excluded region or LD rule, genome build, weights, scaling and denominators must be defined. In the relevant subset with protein measurements, also assess how well both scores predict TIMP2. Overlapping people and correlated scores require an appropriate uncertainty analysis.

== How the decision would work ==
{| class="wikitable"
! Possible finding !! Permitted conclusion
|-
| The cognitive association persists with preserved protein prediction. || This weakens the explanation that the excluded region alone carries the score finding. TIMP2 mediation remains unproven.
|-
| Precise attenuation, defined in advance as relevant, despite adequate protein prediction. || This weakens the APOE-independent interpretation of this score. It does not prove an APOE mechanism.
|-
| Weak protein prediction, wide intervals or merely a switch from p<0.05 to p>0.05. || Inconclusive. No demonstration that TIMP2 has no effect.
|}

These are '''hypothetical decision rules''', not completed comparisons. A numerical threshold without a substantive justification would be invented. Alternative variant thresholds should be prespecified and all results reported; selecting only the most favourable would not establish robustness. A single weak cis marker cannot reliably refute a mechanism.

== Next executable step and remaining limits ==
The AG-D06 supplement check is parked pending concrete new access to original material. When available, inspect variant lists and models first, rather than further general summaries. The next separate work route is a targeted check of accessible original methods in '''AG-R05, Castellano et al., DOI 10.1038/nature22067, online 19 April 2017''', covering direct functional comparisons, experimental units and duration after TIMP2 administration. The registry currently contains abstract/metadata appraisal only; this is not a new finding today. [https://www.nature.com/articles/nature22067 Queued original source].

* '''Established within the audit:''' Single-variant testing, stratification and recomputed scores ask different questions.
* '''Promising indication:''' Yesterday's documented human association warrants further scrutiny, not a treatment recommendation.
* '''Experimental findings:''' No new intervention or data analysis today; existing animal findings unchanged.
* '''Hypothesis:''' TIMP2 mediates functional benefit. Alternative genetic, neuronal and matrix pathways remain open.

No new efficacy, durability or safety evidence. Axolotl gaps unchanged. Source delta '''0'''; still '''28 studies'''. Targeted correction/current-result search yielded no suitable new TIMP2 evidence or correction notice; non-exhaustive. Professor assignments AG-P14/17 cover this methodological refinement without a duplicate wish. [[Aging/Search log|Search log]] · [[Aging/Evidence chain|Evidence chain]] · [[Aging/Approaches to aging|Approaches registry]] · [[Aging/Research colloquium|Research colloquium]].

</div>
<div class="aj-section-title"><h2>Continue exploring</h2></div><div class="aj-tiles"><div class="aj-tile"><div class="aj-thumb">[[File:Bovine Pulmonary Artery Endothelial Cells Fluorescent Image.jpg|120px|frameless|link=Aging/Approaches to aging|alt=Fluorescence micrograph of bovine endothelial cells with labeled nuclei, actin and mitochondria.]]</div><div><div class="aj-tile-title">[[Aging/Approaches to aging|Approaches to aging]]</div><div class="aj-tile-desc">Evidence and functional outcomes</div></div></div><div class="aj-tile"><div class="aj-thumb aj-type-thumb">[[Aging/Evidence chain|→]]</div><div><div class="aj-tile-title">[[Aging/Evidence chain|Evidence chain]]</div><div class="aj-tile-desc">How studies generate new questions</div></div></div><div class="aj-tile"><div class="aj-thumb">[[File:DNA double helix.svg|120px|frameless|link=Aging/Research colloquium|alt=Schematic illustration of a DNA double helix.]]</div><div><div class="aj-tile-title">[[Aging/Research colloquium|Research colloquium]]</div><div class="aj-tile-desc">16 foundation assignments + 4 new deep dives</div></div></div></div>
<div class="aj-footer"><div class="aj-brand"><span class="aj-monogram">[[Aging|a.]]</span><span>[[Aging|AGING]]<small>RESEARCH IN PROGRESS</small></span></div><div class="aj-context">[[Aging|Project overview]][[Aging/About the project|Goals & methods]][[Aging/Evidence chain|Evidence chain]]</div><div class="aj-meta">AI-assisted literature research and model building. No laboratory or clinical studies conducted by this project. No personal treatment plans.</div><div class="aj-credits">Image credits · Illustrations, not project data: [https://commons.wikimedia.org/wiki/File:Axolotl_Portrait.jpg Axolotl] — LoKiLeCh ([https://creativecommons.org/licenses/by-sa/3.0/ CC BY-SA 3.0]) · [https://commons.wikimedia.org/wiki/File:XBio_illustration_%E2%80%93_Neuron.png Neuron] — explorebiology (Explore Biology) ([https://creativecommons.org/licenses/by/4.0/ CC BY 4.0]) · [https://commons.wikimedia.org/wiki/File:DNA_double_helix.svg DNA] — Biochemlife ([https://creativecommons.org/licenses/by-sa/4.0/ CC BY-SA 4.0]) · [https://commons.wikimedia.org/wiki/File:Bovine_Pulmonary_Artery_Endothelial_Cells_Fluorescent_Image.jpg Bovine endothelial cells] — Erin Rod ([https://creativecommons.org/licenses/by/4.0/ CC BY 4.0])</div></div>
</div>
[[Category:Altern / Aging]]

Aging/Research reports/2026-10-08 - Versionsgeschichte

Glanz: Aging daily 1c935eb4987f40b494f80d5f78276ffc 95672e319d13